Showing results (671-680 of 2,697) with videos related to

Sort By:
Pageof 270
HLA|October 8, 2019
HLA-DQB1*04:02:13, an HLA-DQB1*04:02 variant, identified in a Kuwaiti individualMohamed Jahromi, Mona Al-Khuwari, Py-Yu Lin, et al.
Rapid Communications in Mass Spectrometry : RCM|March 14, 2019
Shoot δ13 C values as an indicator of cumulative stress: The role of re-watering during drought and salinity stressLuan Zi Sun, Lu Liu, Mengyu Zhang, et al.
International Journal of Molecular Medicine|July 25, 2012
Novel GATA6 loss-of-function mutation responsible for familial atrial fibrillationJian Li, Wei-Dong Liu, Zhong-Liang Yang, et al.
Bioengineering (Basel, Switzerland)|October 28, 2023
Implicit HbA1c Achieving 87% Accuracy within 90 Days in Non-Invasive Fasting Blood Glucose Measurements Using PhotoplethysmographyJustin Chu, Yao-Ting Chang, Shien-Kuei Liaw, et al.
Nature Communications|January 4, 2017
Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activityMarjolein Soethoudt, Uwe Grether, Jürgen Fingerle, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|March 7, 2024
Determinants of Mortality and Mid-Term Outcomes After Transcarotid Artery Revascularization and Transfemoral Carotid Artery StentingJerry Zhu, Ajit Rao, Kelsey Berger, et al.
ACS Chemical Neuroscience|April 30, 2015
Effects of bioisosteric fluorine in synthetic cannabinoid designer drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135Samuel D Banister, Jordyn Stuart, Richard C Kevin, et al.
Pharmacology, Biochemistry, and Behavior|April 6, 2020
In vitro and in vivo pharmacological evaluation of the synthetic cannabinoid receptor agonist EG-018Thomas F Gamage, Daniel G Barrus, Richard C Kevin, et al.
Pageof 270